ID Board Review/Fungi

rightFungi account for 5% of the ABIM ID Certification Exam.https://www.abim.org/Media/mucpauyz/infectious-disease.pdf Based off the ABIM blueprint, therapies, specific diagnostic testing and syndromes may be emphasized more than Bacterial or Viral Diseases. Yeasts Candida spp Cryptococcus Other yeasts Trichosporon Saccharomyces Endemic mycoses /Histoplasma/ Blastomyces dermatitidis Coccidioides spp Coccidioides immitis Coccidioides posadasii Sporothrix schenckii Paracoccidioides brasiliensis Talaromyces marneffei (Previously Penicillium marneffei) /Molds/ Hyaline Molds Aspergillus spp Agents of Zygomycosis (mucormycosis) Dematiaceous Molds Bipolaris Exophiala Others:Scedosporium apiospermum/Pseudallescheria Boydii Superficial and subcutaneous mycoses Mycetoma Chromoblastomycosis Malassezia Dermatophytes Pneumocystis jirovecii pneumonia (PJP) Therapy Pharmacokinetics Drug interactions Spectrum Toxicity Prophylaxis Susceptibility testing Drug resistance Diagnostic testing Histopathology Culture Nonculture methods Syndromes Mucosal Skin Pulmonary Central nervous system and eyes Cardiac Disseminated